Healthcare -
Biotechnology - NASDAQ - US
$ 1.155
-1.28 %
$ 3.66 M
Market Cap
-0.1
P/E
SONN - REVENUE
Revenue SONN - Sonnet BioTherapeutics Holdings, Inc.
18.6 K
LAST VALUE
-76.93%
2 YEAR CAGR
-78.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR